Welcome Remarks and Plenary Session: The Cell and Gene Therapy Sector's Commercial Trailblazers

Welcome Remarks and Plenary Session: The Cell and Gene Therapy Sector's Commercial TrailblazersПодробнее

Cell & Gene Therapy Trailblazers - Process Development - Chapter 2: ‘DEVELOP & INDUSTRIALIZE’Подробнее

Plenary Session: The Evolution of Commercial Cell TherapyПодробнее

Plenary Session: Current Trends and Challenges Surrounding Gene Therapy CommercializationПодробнее

Welcome Remarks & Plenary Session: Lessons from Pioneers of Cell & Gene Therapy CommercializationПодробнее

Plenary Session: How Can We Successfully Commercialize ATMPS in Europe?Подробнее

Plenary Session: Cell Therapy Commercialization Today and Preparing for the FutureПодробнее

2025 Cell & Gene State of the Industry Briefing: Introduction and Industry UpdateПодробнее

Plenary Session: Commercial Strategies From Pathfinders in the IndustryПодробнее

CMC challenges in cell and gene therapy manufacturingПодробнее

Cell & Gene Therapy Trailblazers - Process Development - Chapter 1: ‘DIAGNOSE TO DE-RISK’Подробнее

FT Pharma 2021 - The next generation of cell and gene therapies sessionПодробнее

Opening Remarks - Regenerative Cell Therapies Event, Sept. 19, 2019Подробнее

Cell & Gene Therapy Trailblazers - Process Development - Chapter 3: ‘DELIVER TO GMP’Подробнее